Of note, the CD28+ cluster was detected also in the tumor, and accordingly it was enriched by ITGA4 (CD49), CCR5 and CD44, all contributing to CD8+ T-cell infiltrative capacity. This evidence concerns the gene CD8A and neoplasm.